Navigation Links
Federal Judge Says Sugar Association Suit Accusing Johnson & Johnson of False Advertising to Go Forward
Date:12/9/2007

LOS ANGELES, Dec. 9 /PRNewswire/ -- A federal court in Los Angeles has opened the door to shining a harsh spotlight on the pharmaceutical firm Johnson & Johnson, whose subsidiary McNeil Nutritionals has been accused of false advertising the controversial chemical sweetener Splenda. United States District Dale S. Fischer rejected Johnson & Johnson's request for summary judgment based on that charge that the plaintiffs had unreasonably delayed bringing suit, and said that the claims against Johnson & Johnson should be heard by a jury at a trial on the merits.

Andy Briscoe, President and CEO of the Washington-based Sugar Association, representing thousands of sugar farmers from across the nation, declared, "This ruling will give consumers a chance to hear the facts in this case. Consumers have a right to know what they really are buying and an equal right not to have a big corporation try to tell them something else. We look forward to the trial."

The central issue before the court is the deceptive nature of the advertising of Splenda -- a chemical sweetener -- to make consumers believe it is a natural product, including the use of the taglines, "Made from sugar, so it tastes like sugar" and "Good for the Whole Family." Internal documents show Johnson & Johnson knew that its Splenda advertising was causing consumers to believe that Splenda, which is made using chlorine, is a natural product, despite it being chemical. Although rulings in France, Australia and New Zealand have found Johnson & Johnson's advertising of Splenda to be deceptive, the company continues to falsely promote Splenda as something that it is not.

Dan Callister, attorney for the Sugar Association, said, "We believe that the facts in this case are clear and compelling. For the second time, a jury will find that Johnson & Johnson has intentionally misled the consumer in its marketing of the chlorinated sweetener Splenda."

It has been estimated that damages in this case could reach $1-billion. The trial currently is scheduled to begin on January 29, 2008, in Los Angeles. Additional background information can be found at http://www.TruthAboutSplenda.com .


'/>"/>
SOURCE Sugar Association
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations
2. MDMA Names New Director of Federal Affairs
3. Federal research plan to determine nanotech risks fails to deliver
4. Federal Employee Program Maintains Low Health Premiums In 2008
5. AMERIGROUP Contracts with Federal Government to Offer Medicare Advantage Health Plans in Seven States
6. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
7. ACM Helps Medicaid Programs Comply With Federal Deficit Reduction Act Mandates
8. Boise(R) BEWARE(TM) Meets New Federal Guidelines Set Forth by Medicaid
9. HIV/AIDS Cases Among State and Federal Prison Inmates Fell for the Sixth Straight Year During 2005
10. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
11. Federal Trade Commission Attempts To Suppress Best-Selling Authors First Amendment Rights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser ... Cancer Institute. For Betsy, the clinical trial has been life-saving as she has ... worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is ... life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater ... spent her career as an educator interacting with countless women who had little knowledge ...
(Date:1/20/2017)... ... ... a fine examination of how God handles sin, including how to let go of ... who, for over ten long years has been waiting to release this powerful insight about ... has been serving the Lord for over twenty years, and he has been preaching and ...
(Date:1/20/2017)... ... ... and enchanting tale that teaches children the true meaning of Christmas. “Journey to Christmas” is ... a devoted woman of faith. , “Becoming a parent changes you. In my case, ... for years, but actually doing it might have been a while in coming if it ...
(Date:1/20/2017)... ... , ... “God's Miracle Man: Against All Odds”: an inspiring affirmation of ... Keith C. A. Tucker, son of Minister Delores Pinnock and a Jamaican native who ... Hardy , “While sitting up in bed, I felt a pounding headache. It was ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Report Details ... Alzheimer,s Disease Therapeutics and ... our new study reveals trends, R&D progress, and predicted ... the Alzheimer,s disease therapeutics and diagnostics market. Our new ... - How is the Alzheimer,s disease therapeutics and diagnostics ...
(Date:1/19/2017)... , January 19, 2017 Incretin Mimetics/GLP-1 ... and Others The global anti-obesity drugs market ... first half of the forecast period and CAGR of 38.7% in ... to grow at a CAGR of 32.8% from 2016 to 2027. ... in 2021, and $24,063 million in 2027. ...
(Date:1/19/2017)... -- James Gilbart , ... 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ...      ... in a supplement to European Oncology & Haematology ... by James Gilbart and Axel ...
Breaking Medicine Technology: